...
首页> 外文期刊>Toxicologic pathology >Particle-induced Pulmonary Alveolar Proteinosis and Subsequent Inflammation and Fibrosis: A Toxicologic and Pathologic Review
【24h】

Particle-induced Pulmonary Alveolar Proteinosis and Subsequent Inflammation and Fibrosis: A Toxicologic and Pathologic Review

机译:颗粒诱导的肺肺泡蛋白病和随后的炎症和纤维化:毒理和病理综述

获取原文
获取原文并翻译 | 示例
           

摘要

This review analyzes the published data on cases of pulmonary alveolar proteinosis (PAP) in workers inhaling crystalline aluminum, indium, silicon, and titanium particles and possible sequelae, that is, inflammation and fibrosis, and compares these findings with those from animal experiments. In inhalation studies in rodents using crystalline indium and gallium compounds, pronounced PAP followed by inflammation and fibrosis down to very low concentration ranges have been reported. Crystalline aluminum, silicon, and titanium compounds also induced comparable pulmonary changes in animals, though at higher exposure levels. Laboratory animal species appear to react to the induction of PAP with varying degrees of sensitivity. The sensitivity of humans to environmental causes of PAP seems to be relatively low. Up to now, no cases of PAP, or other pulmonary diseases in humans, have been described for gallium compounds. However, a hazard potential can be assumed based on the results of animal studies. Specific particle properties, responsible for the induction of PAP and its sequelae, have not been identified. This review provides indications that, both in animal studies and in humans, PAP is not often recognized due to the absence of properly directed investigation or is concealed behind other forms of lung pathology.
机译:该综述分析了吸入结晶铝,铟,硅和钛颗粒的工人肺肺泡蛋白症(PAP)的发布数据,即可能的后遗症,即炎症和纤维化,并将这些发现与动物实验的那些进行比较。在使用结晶铟和镓化合物的啮齿动物的吸入研究中,已报道炎症,然后据报道炎症,纤维化下降至非常低的浓度范围。结晶铝,硅和钛化合物也诱导动物的可比肺部变化,但在较高的曝光水平下。实验室动物物种似乎对PAP诱导反应,具有不同程度的敏感性。人类对PAP环境原因的敏感性似乎相对较低。到目前为止,已经描述了对镓化合物描述了对人类的呕吐物或其他肺病的病例。然而,可以基于动物研究的结果来假设危险潜力。尚未确定对诱导罂粟和其后遗症的诱导的特异性颗粒性质。本综述提供了迹象,既由于缺乏正确指导调查或隐藏在其他形式的肺病学之后,患有动物研究和人类的迹象表明,PAP都不会经常被认可。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号